Two Swedish case-control studies have reported that the benefits of sun exposure in MS patients occur largely independently of vitamin D (Hedstrom et al. J Neurol 2020;267:1045-1052). The finding has particular relevance during the current COVID-19 pandemic as patients self-isolate indoors.
Neurology
Treatment optimization in MS – new Canadian recommendations
May 15, 2020The Canadian MS Working Group, under the aegis of the Canadian Network of MS Clinics, has released new recommendations on optimizing the treatment of multiple sclerosis (Freedman et al. Can J Neurol Sci 2020; online April 6, 2020; see link below). The paper updates the group’s prior recommendations published seven years ago (Freedman et al. Can J Neurol Sci 2013;40:307-323).
AAN 2020 DAILY REPORT – THURSDAY, APRIL 30 EDITION
April 30, 2020The American Academy of Neurology (AAN) annual meeting, scheduled for April 25-May 1, 2020, was cancelled due to the COVID-19 pandemic. The following summarizes some of the new research that would have been presented at AAN 2020.
AAN 2020 DAILY REPORT – WEDNESDAY, APRIL 29 EDITION
April 29, 2020The American Academy of Neurology (AAN) annual meeting, scheduled for April 25-May 1, 2020, was cancelled due to the COVID-19 pandemic. The following summarizes some of the new research that would have been presented at AAN 2020.
AAN 2020 DAILY REPORT – TUESDAY, APRIL 28 EDITION
April 28, 2020The American Academy of Neurology (AAN) annual meeting, scheduled for April 25-May 1, 2020, was cancelled due to the COVID-19 pandemic. The following summarizes some of the new research that would have been presented at AAN 2020.